Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-30 @ 6:51 PM
Study NCT ID:
NCT02637232
Status:
COMPLETED
Last Update Posted:
2021-05-28
First Post:
2015-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
None
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-16
First Submit QC Date:
None
Study First Post Date:
2015-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-15
Results First Submit QC Date:
None
Results First Post Date:
2021-05-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-06
Last Update Post Date:
2021-05-28
Last Update Post Date Type:
ACTUAL